KaloBios Reports Second Quarter Financial Results and Provides Clinical Update

FREE Breaking News Alerts from StreetInsider.com!

StreetInsider.com Top Tickers, 10/11/2026

1. SPCX
2. HUM
3. ALHC
4. PEP
5. T

6. SPY
7. CVS
8. UNH
9. AXP
10. TMUS

KaloBios Pharma (KBIO) Tops Q2 EPS by 22c

August 10, 2015 8:05 AM EDT

KaloBios Pharma (NASDAQ: KBIO) reported Q2 EPS of ($1.46), $0.22 better than the analyst estimate of ($1.68).

For earnings history and earnings-related data on KaloBios Pharma (KBIO) click here.

... More